Verso Corp (VRS)

NYSE

Currency in USD

26.99

0.00(0.00%)

Real-time Data30/03

Fair Value

Day's Range

26.99

27.01

52 wk Range

26.99

27.01

VRS Income Statement

Explore the detailed Verso Corp income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Verso Corp's growth trends and overall financial health.

Advanced Income Statement

Period Ending:

2012

31/12

2013

31/12

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

Total Revenues

2,461

2,682

2,444

1,359

1,278

Total Revenues Growth

-6.82%

+8.98%

-8.87%

-44.39%

-5.96%

Cost Of Revenues

2,250

2,321

2,138

1,314

1,049

Gross Profit

211

361

306

45

229

Gross Profit Growth

-20.38%

+71.09%

-15.24%

-85.29%

+408.89%

Gross Profit Margin %

8.57%

13.46%

12.52%

3.31%

17.92%

Other Operating Expenses, Total

201

217

193

152

125

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-23.28%	+7.96%	-11.06%	-21.24%	-17.76%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	91	102	82	59	60
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1	4	4	5	-5

Operating Income

10

144

113

-107

104

Operating Income Growth

+233.33%

+1,340%

-21.53%

-194.69%

+197.2%

EBIT Margin %

0.41%

5.37%

4.62%

-7.87%

8.14%

Net Interest Expenses

-38

-33

-2

-1

-2

Net Interest Expenses Growth

+32.14%

+13.16%

+93.94%

+50%

-100%

Interest Expense, Total

-38

-33

-2

-1

-2

Interest And Investment Income

-

-

-

-

-

Other Non Operating Expenses, Total

4

10

-

-1

-

EBT, Excl. Unusual Items

-24

121

111

-109

102

Gain (Loss) On Sale Of Assets

-

9

-

94

-3

Other Unusual Items, Total

-5

42

-4

-18

2

EBT, Incl. Unusual Items

-38

171

-21

-110

-6

EBT, Incl. Unusual Items Growth

-103.37%

+550%

-112.28%

-423.81%

+94.55%

EBT, Incl. Unusual Items Margin

-1.54%

6.38%

-0.86%

-8.09%

-0.47%

Income Tax Expense

-8

-

-91

-9

-3

Net Income to Company

-30

171

70

-101

-3

Minority Interest

-

-

-

-

-

Net Income

-30

171

70

-101

-3

Net Income Growth

-102.62%

+670%

-59.06%

-244.29%

+97.03%

Net Income Margin %

-1.22%

6.38%

2.86%

-7.43%

-0.23%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

-30

171

70

-101

-3

Basic EPS - Continuing Operations

-0.87

4.95

2.02

-2.95

-0.1

Basic EPS - Continuing Operations Growth

-104.55%

+668.65%

-59.2%

-245.94%

+96.71%

Diluted EPS - Continuing Operations

-0.87

4.88

2

-2.95

-0.1

Diluted EPS - Continuing Operations Growth

-104.55%

+660.09%

-59.02%

-247.52%

+96.71%

Basic Weighted Average Shares Outstanding

34.43

34.51

34.63

34.23

30.87

Diluted Weighted Average Shares Outstanding

34.43

35.1

35.13

34.23

30.87

Dividend Per Share

-

-

-

-

0.4

Dividend Per Share Growth

-

-

-

-

-

EBITDA

119

255

220

-19

174

EBITDA Growth

-22.22%

+114.29%

-13.73%

-108.64%

+1,015.79%

EBITDA Margin %

4.84%

9.51%

9%

-1.4%

13.62%